The GM contributes to obesity pathogenesis through multiple mechanisms, including SCFA-mediated regulation of energy homeostasis and insulin sensitivity, LPS-induced chronic inflammation, modulation of host metabolic and appetite-regulating genes, and alterations in BA signaling via FXR. Here, NR1H4 is linked to obesity disorder.